Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Sep 15;7(9):e607.
doi: 10.1038/bcj.2017.89.

Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis

Affiliations
Case Reports

Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis

C L Haddox et al. Blood Cancer J. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Dr Mark Litzow receives research support for clinical trials from Amgen. The remaining authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Distinct morphologic and immunophenotypic features of B-ALL blasts and AML blasts following lineage switch. (a) The lymphoblasts of B-ALL had scant cytoplasm, round nuclei, fine chromatin and inconspicuous nucleoli. (b) The myeloid blasts of AML had abundant cytoplasm, folded nuclei, fine chromatin and occasional prominent nucleoli. (c and d) Bone marrow biopsy revealed packed B-lymphoblasts with scant cytoplasm and myeloid blasts with more abundant cytoplasm, respectively. (e, g, and i) show that the lymphoblasts expressed dim CD45, lower side scatter, CD19, CD34 (partial), and terminal deoxynucleotidyl transferase (TdT). They were negative for myeloperoxidase (MPO). (f, h and j) show that the myeloid blasts expressed bright CD45, high side scatter and MPO, but are negative for CD19, CD34 and TdT.

References

    1. Stass S, Mirro J, Melvin S, Pui CH, Murphy SB, Williams D. Lineage switch in acute leukemia. Blood 1984; 64: 701–706. - PubMed
    1. Meyer C, Hofmann J, Burmeister T, Gröger D, Park TS, Emerenciano M et al. The MLL recombinome of acute leukemias in 2013. Leukemia 2013; 27: 2165–2176. - PMC - PubMed
    1. Schrappe M, Hunger SP, Pui CH, Saha V, Gaynon PS, Baruchel A et al. Outcomes after induction failure in childhood acute lymphoblastic leukemia. N Engl J Med 2012; 366: 1371–1381. - PMC - PubMed
    1. Marchesi F, Girardi K, Avvisati G. Pathogenetic, clinical, and prognostic features of adult t(4;11)(q21;q23)/MLL-AF4 positive B-cell acute lymphoblastic leukemia. Adv Hematol 2011; 2011: 621627. - PMC - PubMed
    1. Hoffmann P, Hofmeister R, Brischwein K, Brandl C, Crommer S, Bargou R et al. Serial killing of tumor cells by cytotoxic T cells redirected with a CD19-/CD3-bispecific single-chain antibody construct. Int J Cancer 2005; 115: 98–104. - PubMed

MeSH terms

LinkOut - more resources